Different T-cell and B-cell repertoire elicited by the SARS-CoV-2 inactivated vaccine and S1 subunit vaccine in rhesus macaques

References

• WHO. WHO Coronavirus (COVID-19) dashboard; 2022 [ accessed 2022 Aug 04]. https://covid19.who.int/.
   Google Scholar
• Feng L, Wang Q, Shan C, Yang C, Feng Y, Wu J, Liu X, Zhou Y, Jiang R, Hu P, et al. An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques. Nat Commun. 2020;11(1):1. doi:10.1038/s41467-020-18077-5.
   PubMed Web of Science ®Google Scholar
• Chen H, Xie Z, Long R, Fan S, Li H, He Z, Xu K, Liao Y, Wang L, Zhang Y, et al. Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques. Mol Ther Methods Clin Dev. 2021;23:108–7. doi:10.1016/j.omtm.2021.08.005.
   PubMed Web of Science ®Google Scholar
• Bettini E, Locci M. SARS-CoV-2 mRNA vaccines: immunological mechanism and beyond. Vaccines (Basel). 2021;9. doi:10.3390/vaccines9020147.
   PubMed Web of Science ®Google Scholar
• Cromer D, Juno JA, Khoury D, Reynaldi A, Wheatley AK, Kent SJ, Davenport MP. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection. Nat Rev Immunol. 2021;21(6):395–404. doi:10.1038/s41577-021-00550-x.
   PubMed Web of Science ®Google Scholar
• Baxter D. Active and passive immunity, vaccine types, excipients and licensing. Occup Med (Lond). 2007;57(8):552–556. doi:10.1093/occmed/kqm110.
   PubMed Web of Science ®Google Scholar
• Sundling C, Phad G, Douagi I, Navis M, Karlsson Hedestam GB. Isolation of antibody V(D)J sequences from single cell sorted rhesus macaque B cells. J Immunol Methods. 2012;386:85–93. doi:10.1016/j.jim.2012.09.003.
   PubMed Web of Science ®Google Scholar
• Meng W, Li L, Xiong W, Fan X, Deng H, Bett AJ, Chen Z, Tang A, Cox KS, Joyce JG, et al. Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells. Mabs. 2015;7(4):707–718. doi:10.1080/19420862.2015.1051440.
   PubMed Web of Science ®Google Scholar
• Zheng H, Li H, Guo L, Liang Y, Li J, Wang X, Hu Y, Wang L, Liao Y, Yang F, et al. Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: a nonhuman primate model of COVID-19 progression. PLoS Pathog. 2020;16(11):e1008949. doi:10.1371/journal.ppat.1008949.
   PubMed Web of Science ®Google Scholar
• Li H, Guo L, Zheng H, Li J, Zhao X, Li J, Liang Y, Yang F, Zhao Y, Yang J, et al. Self-assembling nanoparticle vaccines displaying the receptor binding domain of SARS-CoV-2 elicit robust protective immune responses in Rhesus monkeys. Bioconjug Chem. 2021;32(5):1034–1046. doi:10.1021/acs.bioconjchem.1c00208.
   PubMed Web of Science ®Google Scholar
• Zheng H, Yang Z, Li B, Li H, Guo L, Song J, Hou D, Li N, Yang J, Wu Q, et al. Single B cells reveal the antibody responses of rhesus macaques immunized with an inactivated enterovirus D68 vaccine. Arch Virol. 2020;165(8):1777–1789. doi:10.1007/s00705-020-04676-6.
   PubMed Web of Science ®Google Scholar
• Zheng H, Wang J, Li B, Guo L, Li H, Song J, Yang Z, Li H, Fan H, Huang X, et al. A novel neutralizing antibody specific to the DE loop of VP1 can inhibit EV-D68 infection in mice. J Immunol. 2018;201(9):2557–2569. doi:10.4049/jimmunol.1800655.
   PubMed Web of Science ®Google Scholar
• Dash P, Wang GC, Thomas PG. Single-cell analysis of T-cell receptor alphabeta repertoire. Methods Mol Biol. 2015;1343:181–197.
   PubMedGoogle Scholar
• Sun X, Saito M, Sato Y, Chikata T, Naruto T, Ozawa T, Kobayashi E, Kishi H, Muraguchi A, Takiguchi M. Unbiased analysis of TCRα/β chains at the single-cell level in human CD8+ T-cell subsets. PLoS One. 2012;7(7):e40386. doi:10.1371/journal.pone.0040386.
   PubMed Web of Science ®Google Scholar
• Miyasaka A, Yoshida Y, Wang T, Takikawa Y. Next-generation sequencing analysis of the human T-cell and B-cell receptor repertoire diversity before and after hepatitis B vaccination. Hum Vaccin Immunother. 2019;15(11):2738–2753. doi:10.1080/21645515.2019.1600987.
   PubMed Web of Science ®Google Scholar
• Yang X, Chen G, Weng NP, Mariuzza RA. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope. J Biol Chem. 2017;292(45):18618–18627. doi:10.1074/jbc.M117.810382.
   PubMed Web of Science ®Google Scholar
• Shomuradova AS, Vagida MS, Sheetikov SA, Zornikova KV, Kiryukhin D, Titov A, Peshkova IO, Khmelevskaya A, Dianov DV, Malasheva M, et al. SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T cell receptors. Immunity 2020, 53:1245–1257 e1245.
   Google Scholar
• Cao Y, Su B, Guo X, Sun W, Deng Y, Bao L, Zhu Q, Zhang X, Zheng Y, Geng C, et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients. B Cells Cell. 2020;182:73–84 e16.
   PubMed Web of Science ®Google Scholar
• Wang Q, Song Z, Yang J, He Q, Mao Q, Bai Y, Liu J, An C, Yan X, Cui B, et al. Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV. Emerg Microbes Infect. 2022;11(1):1145–1153. doi:10.1080/22221751.2022.2059404.
   PubMed Web of Science ®Google Scholar
• Garrido C, Curtis AD, Dennis M, Pathak SH, Gao H, Montefiori D, Tomai M, Fox CB, Kozlowski PA, Scobey T, et al. SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques. Sci Immunol. 2021;6(60). doi:10.1126/sciimmunol.abj3684.
   PubMed Web of Science ®Google Scholar
• Zheng H, Chen Y, Li J, Li H, Zhao X, Li J, Yang F, Li Y, Liu C, Qin L, et al. Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques. Cell Rep. 2022;39(8):110864. doi:10.1016/j.celrep.2022.110864.
   PubMed Web of Science ®Google Scholar
• Schultheiss C, Paschold L, Simnica D, Mohme M, Willscher E, von Wenserski L, Scholz R, Wieters I, Dahlke C, Tolosa E, et al. Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease. Immunity. 2020;53(2):442–455 e444. doi:10.1016/j.immuni.2020.06.024.
   PubMed Web of Science ®Google Scholar
• Hou D, Chen C, Seely EJ, Chen S, Song Y. High-throughput sequencing-based immune repertoire study during infectious disease. Front Immunol. 2016;7:336. doi:10.3389/fimmu.2016.00336.
   PubMed Web of Science ®Google Scholar
• Luo L, Liang W, Pang J, Xu G, Chen Y, Guo X, Wang X, Zhao Y, Lai Y, Liu Y, et al. Dynamics of TCR repertoire and T cell function in COVID-19 convalescent individuals. Cell Discov. 2021;7(1):89. doi:10.1038/s41421-021-00321-x.
   PubMed Web of Science ®Google Scholar
• Zollner A, Watschinger C, Rossler A, Farcet MR, Penner A, Bohm V, Kiechl SJ, Stampfel G, Hintenberger R, Tilg H, et al. B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19. EBioMedicine. 2021;70:103539. doi:10.1016/j.ebiom.2021.103539.
   PubMed Web of Science ®Google Scholar
• Sangesland M, Ronsard L, Kazer SW, Bals J, Boyoglu-Barnum S, Yousif AS, Barnes R, Feldman J, Quirindongo-Crespo M, McTamney PM, et al. Germline-encoded affinity for cognate antigen enables vaccine amplification of a human broadly neutralizing response against influenza virus. Immunity. 2019;51(4):735–749 e738. doi:10.1016/j.immuni.2019.09.001.
   PubMed Web of Science ®Google Scholar
• D’Angelo S, Ferrara F, Naranjo L, Erasmus MF, Hraber P, Bradbury ARM. Many routes to an antibody heavy-chain CDR3: necessary, yet insufficient, for specific binding. Front Immunol. 2018;9:395. doi:10.3389/fimmu.2018.00395.
   PubMed Web of Science ®Google Scholar
• Barrios Y, Jirholt P, Ohlin M. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor. J Mol Recognit. 2004;17(4):332–338. doi:10.1002/jmr.679.
   PubMed Web of Science ®Google Scholar